Prognostic assessment in patients operated for brain metastasis from systemic tumors
Cancer Medicine · 2023
DOI: 10.1002/cam4.5928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Bettina Grossenbacher und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Clinical Neuroscience Center, University Hospital of Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Brain Neoplasms, Neoplasm Metastasis, Central Nervous System Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Established models for prognostic assessment in patients with brain metastasis do not stratify for prior surgery. Here we tested the prognostic accuracy of the Graded Prognostic Assessment (GPA) score model in patients operated for BM and explored further prognostic factors.
Methods
We included 285 patients operated for brain metastasis at the University Hospital Zurich in the analysis. Information on patient characteristics, imaging, staging, peri‐ and postoperative complications and survival were extracted from the files and integrated into a multivariate Cox hazard model.
Results
The GPA score showed an association with outcome. We further identified residual tumor after surgery ( p = 0.007, hazard ratio (HR) 1.6, 95% confidence interval (CI) 1.1–2.3) steroid use ( p = 0.021, HR 1.7, 95% CI 1.1–2.6) and number of extracranial metastasis sites ( p = 0.009, HR 1.4, 95% CI 1.1–1.6) at the time of surgery as independent prognostic factors. A trend was observed for postoperative infection of the subarachnoid space ( p = 0.102, HR 3.5, 95% CI 0.8–15.7).
Conclusions
We confirm the prognostic capacity of the GPA score in a cohort of operated patients with brain metastasis. However, extent of resection and steroid use provide additional aid for the prognostic assessment in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Clinical Neuroscience Center, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
- Department of Neuroradiology, Clinical Neuroscience Center, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
- Department of Neurosurgery, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Fabian Wolpert
Zitieren
APA
Grossenbacher, B., Lareida, A., Moors, S., Roth, P., Kulcsar, Z., Regli, L., Le Rhun, E., Weller, M., & Wolpert, F. (2023). Prognostic assessment in patients operated for brain metastasis from systemic tumors. Cancer Medicine. https://doi.org/10.1002/cam4.5928
Vancouver
Grossenbacher B, Lareida A, Moors S, Roth P, Kulcsar Z, Regli L, et al. Prognostic assessment in patients operated for brain metastasis from systemic tumors. Cancer Medicine. 2023. doi:10.1002/cam4.5928
BibTeX
@article{Grossenbacher2023,
author = {Grossenbacher, Bettina and Lareida, Anna and Moors, Selina and Roth, Patrick and Kulcsar, Zsolt and Regli, Luca and Le Rhun, Emilie and Weller, Michael and Wolpert, Fabian},
title = {Prognostic assessment in patients operated for brain metastasis from systemic tumors},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5928}
}
EUVIMED